Publications by authors named "Sarasa I"
Objective: The use of nutritional supplements to treat hypercholesterolemia is gradually increasing, however further studies on their efficacy and safety are required.
Patients And Methods: The present clinical trial included patients with moderate hypercholesterolemia and cardiovascular risk who were treated either with a nutraceutical preparation containing 3.75mg of monacolin K, 515mg of berberine and 50mg of coenzyme Q10 per tablet (Lipok®) or with a placebo.
Article Synopsis
- Statins are medicines that help lower cholesterol but might increase the risk of diabetes, especially in people with prediabetes.
- A study looked at 407 patients who were using different statins and found that those on pitavastatin had better blood sugar levels compared to those on atorvastatin and simvastatin.
- The research suggests that some statins, like simvastatin and high doses of atorvastatin, might make it harder to control blood sugar compared to others like pitavastatin or pravastatin.
Purpose: We examined the association between dietary folate intake and a score of MetS (metabolic syndrome) and its components among older adults at higher cardiometabolic risk participating in the PREDIMED-Plus trial.
Methods: A cross-sectional analysis with 6633 with overweight/obesity participants with MetS was conducted. Folate intake (per 100 mcg/day and in quintiles) was estimated using a validated food frequency questionnaire.
[New perspectives in the treatment of hypercholesterolaemia since the availability of PCSK9 inhibitors].
Hipertens Riesgo Vasc
May 2020
The large clinical trials on cardiovascular prevention have demonstrated that the more atherogenic cholesterol is reduced the greater the preventive benefit, and neither a threshold value below which that effect disappears nor negative effects on health have been observed. Therefore, the objectives of hypercholesterolaemia control in patients at high cardiovascular risk are becoming ever stricter. The fact that most high-risk patients do not achieve these objectives requires, among other measures, rational use of available lipid-lowering drugs, including monoclonal antibodies that inhibit the protein PCSK9 (PCSK9i).
View Article and Find Full Text PDFIntroduction: This is a prospective descriptive study of intervention without aleatory assignation, carried out in the Chantrea Health Centre. Its aim is to determine the characteristics of the smokers who are taking part in two interventions by the Smokers' Aid Program (Programa de Ayuda al Fumador-PAF), and to evaluate the factors that influence the latter's success.
Material And Methods: The characteristics of 100 smokers were analyzed.